SCHEMBL19998686

SCHEMBL19998686

c1ccc(-c2ccc(N(c3ccccc3)c3ccc(-c4ccc(N(c5ccccc5)c5ccc(-c6ccccc6-c6ccccc6)cc5)cc4)cc3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
KDM4E B2RXH2 1/20 0.50
CYP2D6 P10635 1/20 0.50
MAPT P10636 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
PTGS2 P35354 1/20 0.42
CRHBP P24387 1/20 0.42
ATM Q13315 1/20 0.42
CRHR2 Q13324 1/20 0.42
TLR9 Q9NR96 1/20 0.42
HSD17B10 Q99714 3/20 0.41
BCL2L1 Q07817 2/20 0.41
MAPK1 P28482 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16305464 1.00 ALDH1A1 (0.50) ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1
SCHEMBL19998693 1.00 ALDH1A1 (0.50) ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1
SCHEMBL16385589 1.00 ALDH1A1 (0.50) ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1
SCHEMBL17811567 1.00 ALDH1A1 (0.50) ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1
SCHEMBL24313408 0.98 ALDH1A1 (0.48) ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1
SCHEMBL16305438 0.98 ALDH1A1 (0.48) ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1
SCHEMBL16305441 0.98 ALDH1A1 (0.48) ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1
SCHEMBL15866018 0.98 ALDH1A1 (0.48) ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1
SCHEMBL22079672 0.98 ALDH1A1 (0.46) ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1
SCHEMBL22079939 0.98 ALDH1A1 (0.46) ALDH1A1L3MBTL1CYP1A2CYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180090687-A1 CROSS-CONJUGATED POLYMER, MATERIAL FOR ELECTRONIC ELEMENT, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD (JP) 2018-03-29 US disclosed
US-20180090687-A1 CROSS-CONJUGATED POLYMER, MATERIAL FOR ELECTRONIC ELEMENT, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD (JP) 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180090687-A1 CROSS-CONJUGATED POLYMER, MATERIAL FOR ELECTRONIC ELEMENT, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT SLC18A1, SLC1A2, SLC43A1 ALDH1A1 764/4885L3MBTL1 1552/4885CYP1A2 290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.